<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="marinedrugs-17-00567-t006" orientation="portrait" position="float">
 <object-id pub-id-type="pii">marinedrugs-17-00567-t006_Table 6</object-id>
 <label>Table 6</label>
 <caption>
  <p>Toxicity studies of GRFT in various cell and animal models.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Models Used</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose Tested</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effects of GRFT</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human cervical explants and rabbits</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Up to 2 μM</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No effect on the production of proinflammatory cytokines and chemokines.
     <break/>No vaginal irritation in rabbits.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B45-marinedrugs-17-00567" ref-type="bibr">45</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human cervical epithelial cells, cervicovaginal cells, and PBMCs</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Up to 84 μM</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Minimal changes in secretion of inflammatory cytokines and chemokines
     <break/>No measurable effect on cell viability and T-cell activation markers.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B43-marinedrugs-17-00567" ref-type="bibr">43</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guinea pig
     <break/>BALB/c mice
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single 50 mg/kg and 10 daily subcutaneous injections of 10 mg/kg </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Minimal overall toxicity.
     <break/>Well tolerated.
     <break/>Increase in spleen and liver mass.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B41-marinedrugs-17-00567" ref-type="bibr">41</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mouse PBMC and BALB/c mice with parenteral administration</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Up to 4 μM in vitro, subcutaneously with a single dose of 10 mg/kg, fourteen daily doses of 10 mg/kg, 2 mg/kg subcutaneous, intravaginal, and intraperitoneal administration</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No mitogenic properties in vitro.
     <break/>No effect on cell surface activation markers or animal fitness.
     <break/>No major organ toxicity with reversible splenomegaly.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B44-marinedrugs-17-00567" ref-type="bibr">44</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rhesus macaques</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intravaginal 0.1% gels</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No change in rental proteome or microbiome</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B42-marinedrugs-17-00567" ref-type="bibr">42</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
